Published in Q J Nucl Med Mol Imaging on March 01, 2007
Molecular imaging of stem cells: tracking survival, biodistribution, tumorigenicity, and immunogenicity. Theranostics (2012) 1.08
Magnet-Bead Based MicroRNA Delivery System to Modify CD133(+) Stem Cells. Stem Cells Int (2016) 0.95
Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging. BMC Med Imaging (2012) 0.87
Molecular imaging: the key to advancing cardiac stem cell therapy. Trends Cardiovasc Med (2013) 0.83
Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium. Int J Cardiovasc Imaging (2010) 0.83
Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells. Int J Cardiovasc Imaging (2009) 0.82
Tracking stem cells for cardiovascular applications in vivo: focus on imaging techniques. Imaging Med (2011) 0.81
In vivo tracking of human placenta derived mesenchymal stem cells in nude mice via ¹⁴C-TdR labeling. BMC Biotechnol (2015) 0.76
SDF1-a facilitates Lin-/Sca1+ cell homing following murine experimental cerebral ischemia. PLoS One (2014) 0.76
Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology. Br J Pharmacol (2013) 0.76
Stem cells as a tool for breast imaging. J Oncol (2012) 0.75
Imaging cardiac stem cell transplantation using radionuclide labeling techniques: clinical applications and future directions. Methodist Debakey Cardiovasc J (2013) 0.75
In Vivo Tracking of Cell Therapies for Cardiac Diseases with Nuclear Medicine. Stem Cells Int (2016) 0.75
High-dose (111)in induces g1 cell cycle arrest and cell death in rat bone marrow mesenchymal stem cells. Nucl Med Mol Imaging (2012) 0.75
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med (1998) 4.34
Immunisation state of young children admitted to hospital and effectiveness of a ward based opportunistic immunisation policy. BMJ (1991) 2.59
Discrimination among thermophilic Campylobacter species by polymerase chain reaction amplification of 23S rRNA gene fragments. J Clin Microbiol (1993) 2.54
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48
Recurrent idiotopes and internal images. EMBO J (1982) 2.39
Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J (1979) 2.30
Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas. J Natl Cancer Inst (1993) 2.16
A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet (2005) 2.11
The complexity of age-related hearing impairment: contributing environmental and genetic factors. Audiol Neurootol (2007) 2.09
Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med (1994) 2.03
Connexin-26 mutations in sporadic non-syndromal sensorineural deafness. Lancet (1998) 1.97
The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity (1996) 1.84
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82
Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia (2012) 1.74
Allelic exclusion of Ly49-family genes encoding class I MHC-specific receptors on NK cells. Nature (1995) 1.71
Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet (1999) 1.69
Mutations in the transcriptional activator EYA4 cause late-onset deafness at the DFNA10 locus. Hum Mol Genet (2001) 1.68
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu. Lung Cancer (2012) 1.66
CRASH syndrome: clinical spectrum of corpus callosum hypoplasia, retardation, adducted thumbs, spastic paraparesis and hydrocephalus due to mutations in one single gene, L1. Eur J Hum Genet (1995) 1.64
Nonsyndromic hearing impairment is associated with a mutation in DFNA5. Nat Genet (1998) 1.63
MASA syndrome is due to mutations in the neural cell adhesion gene L1CAM. Nat Genet (1994) 1.62
A common founder for the 35delG GJB2 gene mutation in connexin 26 hearing impairment. J Med Genet (2001) 1.61
Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet (2001) 1.57
A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet (2004) 1.56
An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation. Bone Marrow Transplant (2002) 1.56
Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54
L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns. Hum Mol Genet (1998) 1.54
Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. I. Renal distribution. Am J Pathol (1986) 1.53
Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood (1990) 1.50
Granulomatous interstitial nephritis. Adv Nephrol Necker Hosp (1984) 1.43
Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation. Leukemia (2003) 1.43
Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood (1992) 1.42
Employment of the anatomical terminology of the Nomina Anatomica in the radiologic literature. Surg Radiol Anat (1995) 1.39
L1-associated diseases: clinical geneticists divide, molecular geneticists unite. Hum Mol Genet (1997) 1.39
Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) DNA sequences are absent in leukapheresis products and ex vivo expanded CD34+ cells from multiple myeloma patients. Br J Haematol (1999) 1.38
Phase II study of sunitinib malate in patients with recurrent high-grade glioma. J Neurooncol (2010) 1.36
Pulmonary Kaposi's sarcoma in patients with acquired immune deficiency syndrome: a clinicopathological study. Thorax (1987) 1.35
A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia (2005) 1.33
Two frequent missense mutations in Pendred syndrome. Hum Mol Genet (1998) 1.31
Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse. Br J Cancer (1997) 1.30
Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro. J Immunol (2000) 1.30
KCNQ4: a gene for age-related hearing impairment? Hum Mutat (2006) 1.29
Genetics of microtia and associated syndromes. J Med Genet (2009) 1.28
Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120). Virology (2000) 1.26
The 5TMM series: a useful in vivo mouse model of human multiple myeloma. Hematol J (2000) 1.25
High prevalence of symptoms of Menière's disease in three families with a mutation in the COCH gene. Hum Mol Genet (1999) 1.25
Mutation analysis of TMC1 identifies four new mutations and suggests an additional deafness gene at loci DFNA36 and DFNB7/11. Clin Genet (2008) 1.21
Identification of mutations in the connexin 26 gene that cause autosomal recessive nonsyndromic hearing loss. Hum Mutat (1998) 1.21
Van Buchem disease (hyperostosis corticalis generalisata) maps to chromosome 17q12-q21. Am J Hum Genet (1998) 1.20
Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3. Br J Cancer (2003) 1.18
Alpha-tectorin involvement in hearing disabilities: one gene--two phenotypes. Hum Genet (1999) 1.17
Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling. J Virol (2001) 1.17
Genotype-phenotype correlation in L1 associated diseases. J Med Genet (1998) 1.16
Destruction of contrast microbubbles by ultrasound: effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation (2001) 1.14
Evidence that the clonogenic cell in multiple myeloma originates from a pre-switched but somatically mutated B cell. Br J Haematol (1994) 1.14
Ultrastructural localization by monoclonal antibodies of brush border antigens expressed by glomeruli. II. Extrarenal distribution. Am J Pathol (1986) 1.13
Mutation of COL11A2 causes autosomal recessive non-syndromic hearing loss at the DFNB53 locus. J Med Genet (2005) 1.11
Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol (2001) 1.10
Endarterial occlusion of carotid-cavernous sinus fistulas using a balloon tipped catheter. Neuroradiology (1974) 1.10
An autosomal recessive nonsyndromic form of sensorineural hearing loss maps to 3p-DFNB6. Genome Res (1995) 1.09
Mutations in the KCNQ4 K+ channel gene, responsible for autosomal dominant hearing loss, cluster in the channel pore region. Am J Med Genet (2000) 1.08
Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer. J Natl Cancer Inst (1998) 1.07
Influence of methodology on the presence and extent of mismatching between 99mTc-MIBI and 123I-BMIPP in myocardial viability studies. J Nucl Med (1999) 1.07
Localization of a gene for otosclerosis to chromosome 15q25-q26. Hum Mol Genet (1998) 1.07
Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment. J Med Genet (2007) 1.07
Identification of a 5' splice site mutation in intron 4 of the L1CAM gene in an X-linked hydrocephalus family. Hum Mol Genet (1994) 1.07
Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med (1995) 1.06
Identification of two different mutations in the PDS gene in an inbred family with Pendred syndrome. J Med Genet (1999) 1.06
In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells. Cancer Res (2000) 1.06
Hearing impairment and neurological dysfunction associated with a mutation in the mitochondrial tRNASer(UCN) gene. Eur J Hum Genet (1999) 1.05
Role of the ECG in initial acute coronary syndrome triage: primary PCI regardless presence of ST elevation or of non-ST elevation. Neth Heart J (2014) 1.05
An autopsy study of the prostate in acquired immunodeficiency syndrome: evidence for excessive apoptosis and intracytoplasmic epithelial inclusions. Arch Pathol Lab Med (1998) 1.05
The clinical spectrum of mutations in L1, a neuronal cell adhesion molecule. Am J Med Genet (1996) 1.04
A Moroccan family with autosomal recessive sensorineural hearing loss caused by a mutation in the gap junction protein gene connexin 26 (GJB2). J Med Genet (1998) 1.04
A locus-specific mutation database for the neural cell adhesion molecule L1CAM (Xq28) Hum Mutat (1996) 1.03
Interest of the ordered subsets expectation maximization (OS-EM) algorithm in pinhole single-photon emission tomography reconstruction: a phantom study. Eur J Nucl Med (2000) 1.03
Consanguineous nuclear families used to identify a new locus for recessive non-syndromic hearing loss on 14q. Hum Mol Genet (1995) 1.01
New gene for autosomal recessive non-syndromic hearing loss maps to either chromosome 3q or 19p. Am J Med Genet (1997) 1.00
Endothelin-3 gene mutations in isolated and syndromic Hirschsprung disease. Eur J Hum Genet (1998) 1.00
[Evidence of similar anti-b4 idiotypes in a3+ phenotype rabbits immunized against the b4 allotype]. C R Seances Acad Sci D (1979) 0.99
Venous territories of the brain. J Neuroradiol (1994) 0.99
Mutation in the zonadhesin-like domain of alpha-tectorin associated with autosomal dominant non-syndromic hearing loss. Eur J Hum Genet (1999) 0.98
Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway. Leukemia (2012) 0.98
Progressive paraparesis due to thoracic extramedullary hematopoiesis in myelofibrosis. Case report. J Neurosurg (1993) 0.97
A new autosomal-dominant locus (DFNA12) is responsible for a nonsyndromic, midfrequency, prelingual and nonprogressive sensorineural hearing loss. Am J Otol (1998) 0.97
Neighboring adipocytes participate in the bone marrow microenvironment of multiple myeloma cells. Leukemia (2007) 0.97
X-linked hydrocephalus and MASA syndrome present in one family are due to a single missense mutation in exon 28 of the L1CAM gene. Hum Mol Genet (1994) 0.97
Localization of a novel gene for nonsyndromic hearing loss (DFNB17) to chromosome region 7q31. Am J Med Genet (1998) 0.97
Determination of the carrier frequency of the common GJB2 (connexin-26) 35delG mutation in the Belgian population using an easy and reliable screening method. Hum Mutat (1999) 0.96
Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse. Br J Cancer (2000) 0.96
Microvascularization of the intracranial dura mater. Surg Radiol Anat (1987) 0.95
Dural fistulae of the tentorium cerebelli. Radioanatomical, clinical and therapeutic considerations. J Neuroradiol (1990) 0.95
Clonally related IgA- and IgE-secreting plasma cells in a myeloma patient. Eur J Haematol (2000) 0.95
Congenital non-syndromal sensorineural hearing impairment due to connexin 26 gene mutations--molecular and audiological findings. Int J Pediatr Otorhinolaryngol (1999) 0.95
Endovascular treatment of intracerebral arteriovenous angiomas. Technique, indications and results. J Neuroradiol (1984) 0.94